HealthPhoto: News-MedicalGLP-1 Drugs Linked to Kidney Protection in Bipolar Disorder Patients
Mayo Clinic researchers discovered that GLP-1 receptor agonists, commonly used for diabetes and weight management, are associated with a reduced risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic kidney disease. This finding suggests potential kidney health benefits of these medications beyond their traditional uses.
News-Medical·




